394 related articles for article (PubMed ID: 8695794)
1. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow.
Scheding S; Media JE; KuKuruga MA; Nakeff A
Blood; 1996 Jul; 88(2):472-8. PubMed ID: 8695794
[TBL] [Abstract][Full Text] [Related]
2. Effects of rhG-CSF, 5-fluorouracil and extramedullary irradiation on murine megakaryocytopoiesis in vivo.
Scheding S; Media JE; Kraut M; Valdivieso M; Nakeff A
Br J Haematol; 1994 Dec; 88(4):699-705. PubMed ID: 7529538
[TBL] [Abstract][Full Text] [Related]
3. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
Scheding S; Media JE; Nakeff A
Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice.
Tanikawa S; Nakao I; Tsuneoka K; Nara N
Exp Hematol; 1989 Sep; 17(8):883-8. PubMed ID: 2475360
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and cell-cycle differences in progenitor cells mobilized by recombinant human interleukin-7 and recombinant human granulocyte colony-stimulating factor.
Grzegorzewski KJ; Komschlies KL; Franco JL; Ruscetti FW; Keller JR; Wiltrout RH
Blood; 1996 Dec; 88(11):4139-48. PubMed ID: 8943848
[TBL] [Abstract][Full Text] [Related]
6. Recombinant murine GM-CSF increases resistance of some factor dependent hematopoietic progenitor cells to low-dose-rate gamma irradiation.
FitzGerald TJ; Henault S; Santucci MA; Anklesaria P; Zak S; Kase K; Farber N; Pierce JH; Ohara A; Greenberger JS
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):323-35. PubMed ID: 2666365
[TBL] [Abstract][Full Text] [Related]
7. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for relapsed non-Hodgkin's lymphoma: blood and bone marrow progenitor growth studies. A phase II Eastern Cooperative Oncology Group Trial.
Lazarus HM; Andersen J; Chen MG; Variakojis D; Mansour EG; Oette D; Arce CA; Oken MM; Gerson SL
Blood; 1991 Aug; 78(3):830-7. PubMed ID: 1859894
[TBL] [Abstract][Full Text] [Related]
8. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
9. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.
Johnsen HE; Jensen L; Gaarsdal E; Hansen PB; Ersbøll J; Hansen NE
Exp Hematol; 1994 Jan; 22(1):80-6. PubMed ID: 7506675
[TBL] [Abstract][Full Text] [Related]
10. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice.
Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD
Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066
[TBL] [Abstract][Full Text] [Related]
11. In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Andrews RG; Briddell RA; Knitter GH; Opie T; Bronsden M; Myerson D; Appelbaum FR; McNiece IK
Blood; 1994 Aug; 84(3):800-10. PubMed ID: 7519077
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the grafting efficiency of transplanted marrow cells by preincubation with interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Tavassoli M; Konno M; Shiota Y; Omoto E; Minguell JJ; Zanjani ED
Blood; 1991 Apr; 77(7):1599-606. PubMed ID: 2009376
[TBL] [Abstract][Full Text] [Related]
13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
14. Mast cell growth factor (C-kit ligand) in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3: in vivo hemopoietic effects in irradiated mice compared to in vitro effects.
Patchen ML; Fischer R; MacVittie TJ; Seiler FR; Williams DE
Biotherapy; 1993; 7(1):13-26. PubMed ID: 7520725
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
16. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
Gallicchio VS; Hughes NK
Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625
[TBL] [Abstract][Full Text] [Related]
17. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
[TBL] [Abstract][Full Text] [Related]
18. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
[TBL] [Abstract][Full Text] [Related]
19. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
20. Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood.
Zauli G; Valvassori L; Capitani S
Blood; 1993 Jan; 81(2):385-90. PubMed ID: 7678515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
